CWM
CRL icon

Curi Wealth Management’s Charles River Laboratories CRL Stock Holding History

Curi Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,018
Closed -$9.46M – 24
2023
Q4 		$9.46M Sell
40,018
-8,699
-18% -$1.71M 1.31% 26
2023
Q3 		$9.55M Sell
48,717
-2,591
-5% -$532K 1.46% 25
2023
Q2 		$10.8M Sell
51,308
-3,190
-6% -$635K 1.46% 24
2023
Q1 		$11M Sell
54,498
-1,653
-3% -$375K 1.58% 22
2022
Q4 		$12.2M Buy
56,151
+19,642
+54% +$4.29M 1.72% 21
2022
Q3 		$7.18M Sell
36,509
-3,907
-10% -$843K 1.19% 33
2022
Q2 		$8.65M Buy
40,416
+16,104
+66% +$3.94M 1.66% 25
2022
Q1 		$6.9M Buy
+24,312
New +$7.5M 1.2% 36

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Curi Wealth Management's CRL Position: Q1 2024 in Review

Curi Wealth Management sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 40,018 shares — an estimated $9.46M sold.

Curi Wealth Management first reported a position in CRL in Q1 2022 and held it in 8 quarters. The position peaked at $12.2M in Q4 2022. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

  • Curi Wealth Management reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
  • Curi Wealth Management sold 40,018 Charles River Laboratories shares in Q1 2024, an estimated $9.46M.
  • Curi Wealth Management first reported a position in Charles River Laboratories in Q1 2022 and held it in 8 quarters.
  • Curi Wealth Management's Charles River Laboratories position peaked at $12.2M in Q4 2022.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Curi Wealth Management's 13F filing for Q1 2024.